Main Street Research’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-152,100
Closed -$256K – 131
2026
Q2
$256K Hold
152,100
– – 0.01% 128
2026
Q1
$201K Buy
+152,100
New +$272K 0.01% 145
2025
Q4
– Sell
-142,100
Closed -$182K – 141
2025
Q3
$182K Buy
+142,100
New +$192K 0.01% 128

Other funds holding PACB

Main Street Research's PACB Position: Q3 2026 in Review

Main Street Research sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 152,100 shares — an estimated $256K sold.

Main Street Research first reported a position in PACB in Q3 2025 and held it in 3 quarters. The position peaked at $256K in Q2 2026. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Main Street Research reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
  • Main Street Research sold 152,100 Pacific Biosciences shares in Q3 2026, an estimated $256K.
  • Main Street Research first reported a position in Pacific Biosciences in Q3 2025 and held it in 3 quarters.
  • Main Street Research's Pacific Biosciences position peaked at $256K in Q2 2026.
  • 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Main Street Research's 13F filing for Q3 2026, filed 16 Nov 2026.